Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis

Heart

Volumn 95, Issue 7, 2009, Pages 555-558

  Thomas, H E ^a   Avery, P J ^a   Ahmed, J M ^b   Edwards, R ^b   Purcell, I ^b   Zaman, A G ^b   Arthur, H M ^a   Keavney, B D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; TROPONIN; VASCULOTROPIN RECEPTOR 2;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL INJURY; CELL ASSAY; CELL COUNT; CLINICAL ARTICLE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HUMAN; HUMAN CELL; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STEM CELL MOBILIZATION; STENT THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 64749098321     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.146662     Document Type: Article

References (22)

1. Bauters C, Isner JM. The biology of restenosis. Progr Cardiovasc Dis 1997;40:107- 16.
2. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
3. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-7.
4. Werner N, Junk S, Laufs U, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003;93:e17-24.
5. Griese DP, Ehsan A, Melo LG, et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 2003;108:2710-5.
6. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002;105:3017-24.
7. Gulati R, Jevremovic D, Witt TA, et al. Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells. Am J Physiol- Heart Circ Physiol 2004;287:H512-7.
8. Schober A, Hoffmann R, Opree N, et al. Peripheral CD34 cells and the risk of instent restenosis in patients with coronary heart disease. Am J Cardiol 2005;96:1116-22.
9. Bonello L, Basire A, Sabatier F, et al. Endothelial injury induced by coronary angioplasty triggers mobilization of endothelial progenitor cells in patients with stable coronary artery disease. J Thromb Haemost 2006;4:979-81.
10. Schomig K, Busch G, Steppich B, et al. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J 2006;27:1032-7.
11. Banerjee S, Brilakis E, Zhang S, et al. Endothelial progenitor cell mobilization after percutaneous coronary intervention. Atherosclerosis 2006;189:70-5.
12. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001;88:167-74.
13. Thomas HE, Redgrave R, Cunnington MS, et al. Circulating endothelial progenitor cells exhibit diurnal variation. Arterioscler Thromb Vasc Biol 2008;28:e21-2.
14. Inoue T, Sata M, Hikichi Y, et al. Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis. Circulation 2007;115:553-61.
15. Jensen LO, Maeng M, Kaltoft A, et al. Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 2007;50:463-70.
16. Butzal M, Loges S, Schweizer M, et al. Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. Exp Cell Res 2004;300:65-71.
17. Imanishi T, Kobayashi K, Kuki S, et al. Sirolimus accelerates senescence of endothelial progenitor cells through telomerase inactivation. Atherosclerosis 2006;189:288-96.
18. Fadini GP, Baesso I, Albiero M, et al. Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau. Atherosclerosis 2008;197:496-503.
19. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 2008;78:413-21.
20. Timmermans F, Van Hauwermeiren F, De Smedt M, et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscl Thromb Vasc Biol 2007;27:1572-9.
21. Case J, Mead LE, Bessler WK, et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007;35:1109-18.
22. Eizawa T, Ikeda U, Murakami Y, et al. Decrease in circulating endothelial progenitor cells in patients with stable coronary artery disease. Heart 2004;90:685-6.